Which countries will report an Ebola case in 2026? Odds & Prediction Markets

Prediction market odds on Kalshi reflect aggregated trader expectations and differ from traditional analyst forecasts, which rely on epidemiological models and expert judgment. Markets incorporate real-time information and financial incentives for accuracy, whereas analyst predictions may lag behind emerging disease surveillance data. Comparing market-implied probabilities to WHO assessments, academic epidemiologists, and public health agency forecasts can reveal where traders see greater or lower risk than institutional experts for Ebola emergence in 2026.

On Kalshi, the top outcome—will a human case of Ebola disease in Republic of the Congo be reported before Jan 1, 2027—is currently priced at 60.0% probability. On Kalshi, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. Traders buy and sell shares reflecting their belief in whether at least one confirmed Ebola case will occur in that country within the specified timeframe. Price discovery occurs through continuous order matching, with volume and bid-ask spreads indicating confidence and liquidity around the outcome.

The market resolves on Jan 1, 2027. Resolution is determined by whether confirmed human cases of Ebola disease are reported in specified countries by that deadline. Outcomes depend on official reports from health authorities, laboratory confirmation, and epidemiological documentation. Each country outcome resolves independently based on whether at least one case meeting clinical and virological criteria is documented and publicly reported by the resolution date.

Key catalysts include confirmed Ebola cases reported by national health ministries or WHO, laboratory-confirmed diagnoses, and disease surveillance alerts. Outbreaks in neighboring regions, changes in animal-to-human transmission risk, public health interventions, and vaccination campaigns could shift probabilities. Media reports of suspected cases, epidemiological investigations, and updates from disease monitoring networks will influence trader expectations. Seasonal factors, healthcare capacity, and cross-border movement patterns in Central Africa may also drive market repricing before Jan 1, 2027.